Multiple cellular mechanisms related to cyclin A1 in prostate cancer invasion and metastasis
about
Cytochrome P450 2J2 is highly expressed in hematologic malignant diseases and promotes tumor cell growthElevated level of Wnt5a protein in localized prostate cancer tissue is associated with better outcomeThe lysine specific demethylase-1 (LSD1/KDM1A) regulates VEGF-A expression in prostate cancerCyclin A1 modulates the expression of vascular endothelial growth factor and promotes hormone-dependent growth and angiogenesis of breast cancer.Cystatin C is downregulated in prostate cancer and modulates invasion of prostate cancer cells via MAPK/Erk and androgen receptor pathways.An epigenetic marker panel for recurrence risk prediction of low grade papillary urothelial cell carcinoma (LGPUCC) and its potential use for surveillance after transurethral resection using urineAndrogen stimulates endothelial cell proliferation via an androgen receptor/VEGF/cyclin A-mediated mechanismAssociation of promoter methylation of VGF and PGP9.5 with ovarian cancer progression.Biliverdin inhibits Toll-like receptor-4 (TLR4) expression through nitric oxide-dependent nuclear translocation of biliverdin reductaseR-Roscovitine (Seliciclib) prevents DNA damage-induced cyclin A1 upregulation and hinders non-homologous end-joining (NHEJ) DNA repairA Limited Role for the Cell Cycle Regulator Cyclin A1 in Murine LeukemogenesisOncogenic activation in prostate cancer progression and metastasis: Molecular insights and future challenges.The ubiquitin-specific protease USP2a enhances tumor progression by targeting cyclin A1 in bladder cancer.Cyclin A1 regulates the interactions between mouse haematopoietic stem and progenitor cells and their niches.miR-93/miR-106b/miR-375-CIC-CRABP1: a novel regulatory axis in prostate cancer progressionHeme oxygenase-1 in macrophages controls prostate cancer progressionPlatelets increase survival of adenocarcinoma cells challenged with anticancer drugs: mechanisms and implications for chemoresistance.Differential effects of estrogen receptor ligands on regulation of dihydrotestosterone-induced cell proliferation in endothelial and prostate cancer cells.Cyclins and cell cycle control in cancer and disease.Carbon monoxide expedites metabolic exhaustion to inhibit tumor growth.Targeted suppression of AR-V7 using PIP5K1α inhibitor overcomes enzalutamide resistance in prostate cancer cells.The ETS factor ESE3/EHF represses IL-6 preventing STAT3 activation and expansion of the prostate cancer stem-like compartment.Gambogic acid inhibits TNF-α-induced invasion of human prostate cancer PC3 cells in vitro through PI3K/Akt and NF-κB signaling pathways.Epigenetic modifications in prostate cancer.A comparative study of hepatitis B virus X protein mutants K130M, V131I and KV130/131MI to investigate their roles in fibrosis, cirrhosis and hepatocellular carcinoma.Arsenic-Induced Activation of the Homeodomain-Interacting Protein Kinase 2 (HIPK2) to cAMP-Response Element Binding Protein (CREB) Axis.Cyclin A1 expression and paclitaxel resistance in human ovarian cancer cells.Cyclin A1 is a transcriptional target of PITX2 and overexpressed in papillary thyroid carcinoma.Infiltrating bone marrow mesenchymal stem cells increase prostate cancer stem cell population and metastatic ability via secreting cytokines to suppress androgen receptor signaling.Phosphorylation of the androgen receptor by PIM1 in hormone refractory prostate cancerInhibitory effects of antagonists of growth hormone-releasing hormone on growth and invasiveness of PC3 human prostate cancer.PCTK3/CDK18 regulates cell migration and adhesion by negatively modulating FAK activityDNA methylation in promoter region as biomarkers in prostate cancer.Decreased expression of updated NESG1 in nasopharyngeal carcinoma: its potential role and preliminarily functional mechanism.The interplay between AR, EGF receptor and MMP-9 signaling pathways in invasive prostate cancer.Identifying a panel of genes/proteins/miRNAs modulated by arsenicals in bladder, prostate, kidney cancers
P2860
Q28297057-86EDE643-891E-4120-A644-83C31063FCC3Q28477590-6BD65528-F446-4FC2-873F-1AC76302BEB8Q28687241-5F970DEF-AD64-4B16-BC91-D1A48F6D0D9CQ31132489-91B54C39-CE1B-4F98-963D-C5F428A143CEQ33517129-FDA21B35-9790-48F3-80EE-AA63A55255EAQ34221765-A40EF07A-F915-4017-A126-963A87A54591Q34784556-64ADCC5C-DA78-4BE1-A9ED-E763C62BFB33Q35004607-843796F2-BF24-4996-94C6-FC5686ACAACCQ35558775-CEDBE684-40C6-443C-9CF5-EFA4D9966CAEQ35574807-6956FCE8-0EDD-4B88-A093-45255FE90774Q35665110-C9B7301B-9286-4C82-A381-9A44988E35C9Q35838821-31443912-E771-4206-8E09-A7E743459557Q35911159-3B425AA5-6861-4787-9BA2-ED40EDE8D48AQ36187891-0574978C-8E26-40A2-A609-79EB4FECF19EQ36414226-29226D12-74D7-4922-A5E6-4AE53165A89FQ36545252-FDEA52EA-CA3D-4A5C-A3EC-D028E442F764Q36619756-BD35377C-54C6-4065-8FE2-301404AF8098Q36642985-D909D2AA-B850-4668-A03F-420A50DBA44AQ36796438-D22A329E-0E27-4406-9CA4-C84B69718311Q37365107-E099ECC2-9BD7-4AD6-8CA9-1EC0C921D55FQ37665251-973F780C-5058-4E51-804B-3423B39D3DB6Q37718285-3CDF596D-B577-4EDB-98DD-B651C4829603Q37729931-64A41C5F-627D-4FF1-9E1D-175972056E88Q38261747-FB6B739E-80A3-47CD-869D-0FDEBD6BB5A2Q38698878-E44ACF25-A0FF-4BD7-952F-F1424C79BD63Q38729120-C4E0B4D6-D32C-4329-AAC6-5982B9A989E6Q38743679-0D942393-8E02-468C-A453-4F1D65E9AB98Q39100515-8510AEF2-BB14-402F-B1E0-8F7F729FE51BQ39136417-EFB7D828-23EC-4A2C-BE41-A8CB2B8D2331Q39276825-857B8F93-C9ED-4447-8946-17CC8EC39AE4Q39317388-C65C3AD5-0FB7-40E2-BD50-196E397916D2Q42126544-D0FC2C7F-33E0-45DC-BEA3-0D1F9FD81E3EQ42261678-9158A0A8-8211-4415-9D12-F30ACB3C9DB3Q53305882-37ED45D2-9A7B-4FA1-83B7-8F30DFCD6C9FQ55425609-80DFFEAE-5CAC-409A-BD12-84B22816926AQ57946325-4EAE6666-7245-4321-BB90-7317B8FF0674
P2860
Multiple cellular mechanisms related to cyclin A1 in prostate cancer invasion and metastasis
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Multiple cellular mechanisms r ...... cancer invasion and metastasis
@ast
Multiple cellular mechanisms r ...... cancer invasion and metastasis
@en
type
label
Multiple cellular mechanisms r ...... cancer invasion and metastasis
@ast
Multiple cellular mechanisms r ...... cancer invasion and metastasis
@en
prefLabel
Multiple cellular mechanisms r ...... cancer invasion and metastasis
@ast
Multiple cellular mechanisms r ...... cancer invasion and metastasis
@en
P2093
P2860
P50
P356
P1476
Multiple cellular mechanisms r ...... cancer invasion and metastasis
@en
P2093
Anders Bjartell
Barbara Wegiel
Elise Nilsson
Leo E Otterbein
Leszek Helczynski
Martina Tinzl
Nishtman Dizeyi
Pirkko Härkönen
P2860
P304
P356
10.1093/JNCI/DJN214
P407
P577
2008-07-08T00:00:00Z